Abstract
BackgroundRectal cancers show a highly varied response to neoadjuvant radiotherapy/chemoradiation (RT/CRT) and the impact of the tumor immune microenvironment on this response is poorly understood. Current clinical tumor regression grading...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have